Article ID Journal Published Year Pages File Type
5702381 Surgical Oncology 2017 17 Pages PDF
Abstract
The evidence base for curatively intended treatments of esophageal and gastroesophageal junction cancer is not very strong. Several on-going trials have the potential to change the gold standard treatments of today.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , ,